GVR Report cover Arterial Cannula Market Size, Share & Trends Report

Arterial Cannula Market Size, Share & Trends Analysis Report By Application (Cardiopulmonary Bypass Surgery, Extracorporeal Membrane Pulmonary Oxygenation), By Size, By End-use, By Region, And Segment Forecasts, 2022 To 2030

  • Report ID: GVR453370
  • Number of Pages: 0
  • Format: Electronic (PDF)

The global aterial cannula market is expected to experience exponential growth over the forecast period majorly due to the increasing prevalence of cardiovascular diseases. For instance, according to the American Heart Association, nearly half of U.S. adults have some type of cardiovascular disease in 2019. Moreover, according to CDC, in 2020, about 20.1 million adults aged 20 and over had coronary artery diseases in the U.S., which is about 7.2% of the country’s total population.

In addition, a favorable reimbursement scenario for cardiac interventions is also expected to boost the growth of the arterial cannula market over the forecast period. For instance, in recent years the Centers for Medicare & Medicaid Services expanded ASC coverage for cardiac interventional procedures which includes endovenous ablation, catheterization procedures, and pacemaker placements. This has resulted in a higher number of patients now opting for these procedures in the ambulatory surgical center. This, in turn, is leading to a higher number of people undergoing cardiac surgeries which is expected to have a huge positive impact on the market and represent lucrative growth opportunities over the forecast period.

Arterial Cannula Market Segmentation



By Application

  • Cardiopulmonary bypass surgery
  • Extracorporeal Membrane Pulmonary Oxygenation (ECMO)
  • Others

By Size

  • 14-16 Fr
  • 17-19 Fr
  • 20-22 Fr
  • 23-25 Fr
  • 26-28 Fr
  • 29- 31 Fr
  • 32-34 Fr
  • 35-36 Fr

By End-use

  • Hospital
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa


Based on application, the cardiopulmonary bypass surgery segment is expected to experience maximum growth over the forecast period. According to a research article published in 2018 by National Center for Biotechnology Information, coronary artery bypass surgery is still the most commonly performed cardiac surgery procedure worldwide, representing annual volumes of approximately 200,000 isolated cases in the US and an average incidence rate of 62 per 100,000 inhabitants in western European countries.This is further expected to increase over the forecast period due to the rising prevalence of cardiac diseases that requires cardiopulmonary bypass surgery.

On the basis of size, the 20-22 Fr is expected to dominate the market due to increased usage of these cannulas in extracorporeal membrane oxygenation which holds the highest market share in the arterial cannula market in terms of application.

Key players manufacturing the arterial cannula include Medtronic, plc., LivaNova plc, Edward Lifesciences, Getinge AB, Fresenius Medical Care, BD, Nipro Corporation, Andocor, Freelife Medical GmbH, Surgical Holdings, and Kangxin Medical.

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.